跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Olzadin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Olzadin
Approved
STANDARD
Olzadin
Sydenham Laboratories Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7554c0efb869e64c
Company
Sydenham Laboratories Inc
Type
Standard
Approval Details
Approval Id
7554c0efb869e64c
Drug Approval Philippines Name
Olzadin
Product Name
Olzadin
Registration Number
DR-XY41242
Brand Name
Olzadin
Generic Name
Olanzapine
Dosage Form
Film Coated Tablet
Dosage Strength
10mg
Manufacturer
Sydenham Laboratories Inc
Trader
Medchoice CNS Pharma Corporation
Issuance Date
27 May 2022
Expiry Date
11 September 2027
Pharmacologic Category
Atypical Antipsychotics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7554c0efb869e64c
Type
Standard
Back to Philippines FDA Approvals